7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Turnstone Biologics Corp.
(NASDAQ:TSBX) 

TSBX stock logo

Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy.

Founded: 2014
IPO Price: $12 (Jul 21, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
Turnstone Biologics Days Receivable Outstanding ttm (DSO)
202311 202312 202401 202402 202403 202404 00.521.051.572.12.623.143.67
Turnstone Biologics Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -4.03-3.46-2.88-2.3-1.73-1.15-0.580
Turnstone Biologics Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -4.11-3.52-2.94-2.35-1.76-1.17-0.590
Turnstone Biologics Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.91.792.693.584.485.386.27
Turnstone Biologics P/S ratio ttm
202311 202312 202401 202402 202403 202404 00.551.11.652.192.743.293.84
Turnstone Biologics (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -1.53-1.31-1.1-0.88-0.66-0.44-0.220
Turnstone Biologics P/B ratio ttm
202311 202312 202401 202402 202403 202404 00.10.20.30.40.50.60.71
No extra charts and metrics for this ticker.